Abstract
Using gene knockout mice of particular genes is one of the most effective methods in conducting successful study on the mode of action of target gene products in targeted organs. So called the knockout technology is now a powerful tool that can lead us to find clear understanding on difficult questions such as the effects of full antagonist against target molecules. Cacna1b ( 1B) gene knockout mouse was generated to study mechanisms of N-type calcium (Ca2+) channel. The model was able to overcome physiological obstacles in studies of N-type Ca2+ channel selective blockers, such as unspecific binding to structurally similar molecules, and failed distribution to targeted organs. In the case of N-type Ca2+ channel studies, knockout technology was successfully applied to various cardiovascular, sympathetic, nociceptive, sleepawake cycles, metabolic and neurodegenerative experiments using homozygous mutants of the 1B gene that turned out to be viable. These studies were able to confirm not only the predicted phenotypes, but were able to present completely unexpected phenotypes that are great interest for future study. Thus the outputs from the knockout mouse studies lead to gain the proof of concept as a drug for specific inhibitors of the gene products and enabled us to make further prediction of side-effects of these inhibitors in the drug discovery and development process.
Keywords: Drug Discovery Process, gene knockout mice, calcium (Ca2+) channel, phenotypes, inhibitors
Current Pharmaceutical Biotechnology
Title: The Utilization of Gene Targeting Models During in Preclinical Study of Drug Discovery Process - Example of Phenotypic and Functional Analysis of Cacna1 βGene Product
Volume: 10 Issue: 2
Author(s): Norimasa Miyamoto, Kana Namiki, Naoki Tokuhara, Mai Uesugi, Eiki Takahashi, Junro Kuromitsu and Yoshitoshi Kasuya
Affiliation:
Keywords: Drug Discovery Process, gene knockout mice, calcium (Ca2+) channel, phenotypes, inhibitors
Abstract: Using gene knockout mice of particular genes is one of the most effective methods in conducting successful study on the mode of action of target gene products in targeted organs. So called the knockout technology is now a powerful tool that can lead us to find clear understanding on difficult questions such as the effects of full antagonist against target molecules. Cacna1b ( 1B) gene knockout mouse was generated to study mechanisms of N-type calcium (Ca2+) channel. The model was able to overcome physiological obstacles in studies of N-type Ca2+ channel selective blockers, such as unspecific binding to structurally similar molecules, and failed distribution to targeted organs. In the case of N-type Ca2+ channel studies, knockout technology was successfully applied to various cardiovascular, sympathetic, nociceptive, sleepawake cycles, metabolic and neurodegenerative experiments using homozygous mutants of the 1B gene that turned out to be viable. These studies were able to confirm not only the predicted phenotypes, but were able to present completely unexpected phenotypes that are great interest for future study. Thus the outputs from the knockout mouse studies lead to gain the proof of concept as a drug for specific inhibitors of the gene products and enabled us to make further prediction of side-effects of these inhibitors in the drug discovery and development process.
Export Options
About this article
Cite this article as:
Miyamoto Norimasa, Namiki Kana, Tokuhara Naoki, Uesugi Mai, Takahashi Eiki, Kuromitsu Junro and Kasuya Yoshitoshi, The Utilization of Gene Targeting Models During in Preclinical Study of Drug Discovery Process - Example of Phenotypic and Functional Analysis of Cacna1 βGene Product, Current Pharmaceutical Biotechnology 2009; 10 (2) . https://dx.doi.org/10.2174/138920109787314999
DOI https://dx.doi.org/10.2174/138920109787314999 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
Call for Papers in Thematic Issues
Artificial Intelligence in Bioinformatics
Bioinformatics is an interdisciplinary field that analyzes and explores biological data. This field combines biology and information system. Artificial Intelligence (AI) has attracted great attention as it tries to replicate human intelligence. It has become common technology for analyzing and solving complex data and problems and encompasses sub-fields of machine ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Potential Factors Induced by Filoviruses that Lead to Immune Supression
Current Molecular Medicine Designing Immunogens to Elicit Broadly Neutralizing Antibodies to the HIV-1 Envelope Glycoprotein
Current HIV Research Virus Diagnostics on Microarrays
Current Pharmaceutical Biotechnology Editorial [ NeuroAIDS: A Neuroscience Problem with Global Impact ]
Current HIV Research Therapeutic Approaches Targeting Pathological Tau Aggregates
Current Pharmaceutical Design The Immune System of Cancer Patients
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry From Mice to Macaques – Animal Models of HIV Nervous System Disease
Current HIV Research Development of Novel miRNA-based Vaccines and Antivirals against Enterovirus 71
Current Pharmaceutical Design Prediction of Potential Targets of an Emerging Zoonotic Paramyxovirus: An Integrated Bioinformatics Analysis
Current Pharmacogenomics and Personalized Medicine Exploring the Role of Nerve Growth Factor in Multiple Sclerosis: Implications in Myelin Repair
CNS & Neurological Disorders - Drug Targets Neurovirulence of SARS CoV2: From Clinical Data to Preclinical Neuropsychological Exploration
Coronaviruses Opiate Addiction Therapies and HIV-1 Tat: Interactive Effects on Glial [Ca<sup>2+</sup>]<sub>i</sub>, Oxyradical and Neuroinflammatory Chemokine Production and Correlative Neurotoxicity
Current HIV Research Novel Genetic and Peptide-Based Strategies Targeting the Bcl-2 Family, an Update
Recent Patents on DNA & Gene Sequences Cerebral Amyloidoses: Molecular Pathways and Therapeutic Challenges
Current Medicinal Chemistry EPO Relies upon Novel Signaling of Wnt1 that Requires Akt1, FoxO3a,GSK-3β, and β-Catenin to Foster Vascular Integrity during Experimental Diabetes
Current Neurovascular Research Astrocyte Signaling and Multiple Sclerosis
Current Signal Transduction Therapy Proinflammatory Cytokines and Chemokines in Neonatal Brain Damage
Current Pediatric Reviews Protective Antiviral Antibodies that Lack Neutralizing Activity: Precedents and Evolution of Concepts
Current HIV Research Potential Pathways for CNS Drug Delivery Across the Blood-Cerebrospinal Fluid Barrier
Current Pharmaceutical Design Benzo[a]pyrene Toxicity and Inflammatory Disease
Current Rheumatology Reviews